5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

(2-Methyl-2H-indazol-4-yl)boronic acid, 95.0%, 100mg

4-Bromo-2-(trifluoromethoxy)iodobenzene, 97.0%, 10g

2-(Benzyloxy)pyridin-3-amine, 95+%, 100mg

4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-, 100mg

Ethyl 4-bromothiophene-3-carboxylate, 97%, 250mg

pUC19/Msp I, 200 µg, 4 x 50 µg

tert-Butyl 2-oxo-5-oxa-8-azaspiro[3.5]nonane-8-carboxylate, 98%, 100mg

5-Iodo-m-xylene, 99.0%, 500g

3-Methoxy-4-nitrobenzoic Acid>98.0%(GC)(T)25g

2-Azetidinecarboxylic acid,3-ethyl-1-methyl, (2S)-, 95.0%, 500mg

1-Mercapto-2-propanol, 95%, 250mg

2-(2,5-Difluoro-phenyl)-pyrrolidine, 95.0%, 5g